Skip To Main Content
Michelle Mello on Muck Rack

Michelle Mello

Stanford
As seen in: HuffPost, Wiley Online Library, blogs.plos.org, PLOS, Stanford University, BMJ Open, BMJ Quality & Safety, Environmental Communication, Taylor & Francis Online, JAMA (The Journal of the American Medical Association) and
Law professor, Stanford Law School; health policy professor, Stanford School of Medicine. Using data to study law. Aging athlete; mom of 2; caller of BS.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michelle

Contact Michelle, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Advertising in AI-Powered Clinical Decision Support Tools

|
By Nina P. Singh, Michelle Mello
| JAMA: Journal of the American Medical Association Verified
Few technologies have taken medicine by storm quite like artificial intelligence (AI)–powered clinical decision support (CDS). Since its 2022 launch, the fastest-growing AI-powered CDS tool, OpenEvidence, has already had more than 40% of US physicians sign up.1 This tool and similar platforms ingest natural language queries and return detailed, evidence-backed differential diagnoses, treatment choices, and more.
Open in Who Shared Issue with article?

Utah’s Experiment With AI-Driven Prescription Renewals

|
By Michelle Mello
| JAMA Health Forum Conversations
In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions.
Open in Who Shared Issue with article?

Navigating Conflicting Vaccination Recommendations

|
By Michelle Mello
| JAMA: Journal of the American Medical Association Verified
Since 1964, the Advisory Committee on Immunization Practices (ACIP) has provided the US Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (HHS) with recommendations that underpin US immunization schedules.
Open in Who Shared Issue with article?
See all 81 licensed articles (89 Total)